Objective The 18-kDa mitochondrial translocator protein (TSPO) was reported to be
upregulated in gliomas. 18 F-GE-180 is a novel 3rd generation TSPO receptor ligand with …

Background PET represents a valuable tool for glioma imaging. In addition to amino acid
tracers such as 18 F-FET, PET targeting the 18-kDa mitochondrial translocator-protein …

Background The 18-kDa translocator protein (TSPO) is overexpressed in brain tumours and
represents an interesting target for glioma imaging. 18 F-GE-180, a novel TSPO ligand, has …

The 18-kDa mitochondrial translocator protein (TSPO) is upregulated in high-grade
astrocytomas and can be imaged by PET using the selective radiotracer 11C-(R) PK11195 …

Purpose Glioma patients, especially recurrent glioma, suffer from a poor prognosis. While
advances to classify glioma on a molecular level improved prognostication at initial …

Purpose In recent years there has been an increase in the development of radioligands
targeting the 18-kDa translocator protein (TSPO). TSPO expression is well documented in …

The 18-kDa translocator protein (TSPO) is gaining recognition as a relevant target in
glioblastoma imaging. However, data on the potential prognostic value of TSPO PET …

Purpose This study aimed to compare the detection performance of [68 Ga] Ga-DOTA-FAPI-
04 and [18F] FDG PET/CT in the patients with various oncological and non-oncological …

Meningiomas are known to express somatostatin receptor 2 (SSTR2). PET using the SSTR2
analog 68Ga-DOTATATE has recently been introduced for imaging of meningiomas …

Imaging studies with PET tracers acting as fibroblast activation protein inhibitors (FAPIs)
show promising results that could usefully complement [18F]-FDG in cancer imaging …